nafamostat has been researched along with Cholestasis in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In infants with biliary atresia, hepatic Granzymes A and B mRNA, but not Perforin, increased at the time of portoenterostomy." | 1.40 | Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia. ( Bezerra, JA; Mourya, R; Shivakumar, P, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shivakumar, P | 1 |
| Mourya, R | 1 |
| Bezerra, JA | 1 |
1 other study available for nafamostat and Cholestasis
| Article | Year |
|---|---|
Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia.
Topics: Animals; Animals, Newborn; Benzamidines; Bile Ducts; Biliary Atresia; CD8-Positive T-Lymphocytes; Ch | 2014 |